Summary
- Current Price
- As of today, IPHA price is $2.05, down -1.48% in the most recent trading session on
- Current Price All-Time High
- IPHA price is currently -82.85% below its historical high of $11.95 set on
- Market Cap
- IPHA current market cap is $229M, up +21.74% over the past 365 days
- Revenue
- IPHA current annual revenue is $3.15M, down -76.96% year-over-year
- Next Earnings
- The next earnings release for IPHA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Innate Pharma S.A. |
| Ticker | NASDAQ: IPHA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | France |
| IPO | |
| Indexes | Not included |
| Website | innate-pharma.com |
| Employees | 181 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $2.05 | ||
| Price, 1D Change | -1.48% | |
| $229M | ||
| - | ||
| - | ||
| 1.60 | ||
| $3.15M | ||
| Revenue, 1Y Change | -76.96% | |
| -$0.62 | ||
| EPS, 1Y Change | +6.16% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.62 | ||
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| $3.15M | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $2.05 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.10 | - | |
| - | -$0.66 | - | |
| - | -$0.62 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $56.11M | - | |
| - | $13.65M | - | |
| - | $3.15M | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +0.45% | ||
| -33.47% | ||
| +21.74% | ||
| -7.68% | ||
| -76.96% | ||
| -93.96% | ||
| +6.16% | ||
| +19.21% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $2.05 | ||
| $1.75 | ||
| $1.95 | ||
| $1.84 | ||
| $2.00 | ||
| $0.05 | ||
| 1.60 | ||
| $0.14 | ||
| 49.49 | ||
| 43.68% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $3.15M | ||
| -$0.62 | ||
| $0.00 | ||
| 0.00% | ||
| -$67.97M | ||
| -2,161.03% | ||
| -$55.50M | ||
| -1,764.54% | ||
| -$66.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -1.04 | ||
| 1.27 | ||
| 1.27 | ||
| - | ||
| - | ||
| -11.15 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 24.90 | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$25.49M | ||
| $40.30M | ||
| $73.66M | ||
| $54.86M | ||
| $99.15M | ||
| $43.04M | ||
| $26.51M | ||
| $10.34M | ||
| $17.67M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $58.65M | ||
| $67.97M | ||
| - | ||
| $0.00 | ||
| $1.56M | ||
| $0.00 | ||
| -$7.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$59.54M | ||
| $8.23M | ||
| $6.85M | ||
| $158.00K | ||
| -$59.70M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| BTIG | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Leerink Partners | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with IPHA
FAQ
- What is the ticker symbol for Innate Pharma S.A.?
- The ticker symbol for Innate Pharma S.A. is NASDAQ:IPHA
- Does Innate Pharma S.A. pay dividends?
- No, Innate Pharma S.A. does not pay dividends
- What sector is Innate Pharma S.A. in?
- Innate Pharma S.A. is in the Healthcare sector
- What industry is Innate Pharma S.A. in?
- Innate Pharma S.A. is in the Biotechnology industry
- What country is Innate Pharma S.A. based in?
- Innate Pharma S.A. is headquartered in France
- When did Innate Pharma S.A. go public?
- Innate Pharma S.A. initial public offering (IPO) was on October 17, 2019
- Is Innate Pharma S.A. in the S&P 500?
- No, Innate Pharma S.A. is not included in the S&P 500 index
- Is Innate Pharma S.A. in the NASDAQ 100?
- No, Innate Pharma S.A. is not included in the NASDAQ 100 index
- Is Innate Pharma S.A. in the Dow Jones?
- No, Innate Pharma S.A. is not included in the Dow Jones index
- When was Innate Pharma S.A. last earnings report?
- Innate Pharma S.A.'s most recent earnings report was on May 13, 2026
- When does Innate Pharma S.A. report earnings?
- The next expected earnings date for Innate Pharma S.A. is September 17, 2026
Data Sources & References
- IPHA Official Website www.innate-pharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1598599/000159859925000042/0001598599-25-000042-index.htm
- IPHA Profile on Yahoo Finance finance.yahoo.com/quote/IPHA
- IPHA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ipha
